Cita APA

Salas, M. Q., Pedraza, A., Charry, P., Suárez-Lledó Grande, M., Rodríguez Lobato, L. G., Brusosa, M., . . . Martínez, C. (2024). Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.

Citación estilo Chicago

Salas, María Queralt|||0000-0003-4567-3682, et al. Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Donors Has More Advantages Than Limitations. 2024.

Cita MLA

Salas, María Queralt|||0000-0003-4567-3682, et al. Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From HLA-Matched Donors Has More Advantages Than Limitations. 2024.

Precaución: Estas citas no son 100% exactas.